Specify a stock or a cryptocurrency in the search bar to get a summary
Kindstar Globalgene Tech Inc
9960Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People's Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research testing laboratories. Kindstar Globalgene Technology, Inc. was founded in 2003 and is headquartered in Wuhan, the People's Republic of China. Address: Biolake D2-1, Wuhan, China
Analytics
WallStreet Target Price
25.06 HKDP/E ratio
115Dividend Yield
2.36 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 9960
Dividend Analytics 9960
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 9960
Stock Valuation 9960
Financials 9960
Results | 2019 | Dynamics |